North China Pharmaceutical Group Corp.
http://www.ncpc.com.cn
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From North China Pharmaceutical Group Corp.
Asia On The Move: Flurry Of Japan Appointments, Changes
The start of the fiscal second half in Japan in October brought a flurry of executive changes and reorganizations at foreign and domestic firms in the country including Allergan, Sandoz and Takeda.
Violations Uncovered At GSK, Pfizer Chinese Plants
Two recently released inspection results by western pharmaceutical regulatory authorities have put GlaxoSmithKline PLC and Pfizer Inc. in the spotlight after both multinationals ran into manufacturing problems in China.
GMP issues, death reports hit Chinese hepatitis B vaccines
China is facing a serious shortage of recombinant hepatitis B vaccines because three major domestic manufacturers – Dalian-based Hissen, Shenzhen-based Bio Kangtai and Tiantan Biological Products of Beijing– officially halted production of their products on 1 January.
Orchid exits Chinese JV on 'flat' prospects but API exports to continue
Orchid Chemicals and Pharmaceuticals' recent exit from its 50:50 manufacturing joint venture in China does not imply that it is moving out of the Chinese market, the Indian company has affirmed. Orchid's plans are seen rather as part of the firm's strategy to consolidate manufacturing operations in India.
Company Information
- Industry
- Pharmaceuticals
- Other Names / Subsidiaries
-
- Huayao Group
- North China Pharmaceutical Group New Drug Research and Development Co Ltd
- North China Pharmaceutical Huasheng Co Ltd
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice